Idorsia is a Swiss pharmaceutical research company in Allschwil, near Basel, Switzerland. After Actelion was bought by Johnson & Johnson in 2017, the Actelion founders, Jean-Paul and Martine Clozel, started their new business, located just across the road from the Actelion headquarters. The company expects to be profitable in 2025. Table current as of May 2, 2022, listing the drugs that have reached at least phase 3 trials. More information...
According to PR-model, idorsia.com is ranked 758,099th in multilingual Wikipedia, in particular this website is ranked 83,529th in Japanese Wikipedia.
The website is placed before net-azur-traitement.com and after kfcthailand.com in the BestRef global ranking of the most important sources of Wikipedia.
